









Markets
/
Stocks
/
nasdaq-ntrb
/

Nutriband Inc

NTRB

View Detailed Chart

7.390USD

+0.180+2.50%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

81.84MMarket Cap

LossP/E TTM



Nutriband Inc

7.390

+0.180+2.50%

Overview Company Financials

Financials

Intraday

30m

Today

+2.50%

5 Days

-13.36%

1 Month

-25.43%

6 Months

+0.41%

Year to Date

+56.90%

1 Year

+30.11%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

BUY

Current Rating

15.000

Target Price

102.98%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

117

Total

Median

Average

Company name

Ratings

Analysts

Nutriband Inc

NTRB

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(7)

Neutral(3)

Buy(3)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.352

Neutral

RSI(14)

43.268

Neutral

STOCH(KDJ)(9,3,3)

24.213

Neutral

ATR(14)

0.655

High Vlolatility

CCI(14)

-109.557

Sell

Williams %R

72.188

Sell

TRIX(12,20)

-0.061

Sell

StochRSI(14)

38.624

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

7.466

Sell

MA10

8.020

Sell

MA20

8.065

Sell

MA50

7.727

Sell

MA100

6.768

Buy

MA200

6.278

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Ticker SymbolNTRB

CompanyNutriband Inc

CEOMr. Gareth Sheridan

Websitehttps://nutriband.com/